“In Aerospace, we talked about roughly being for the year at 26%, and that's kind of where it's going to be for the year.”

In context

“m. What's happening sequentially versus the first quarter, first, operationally, nothing is changing. We're doing extremely well on stranded cost takeout, that's ahead of plan. Pricing will be above 3% again. So feel good about what we're doing on pricing and the teams are progressing well. What's happening in the second quarter sequentially, we have, I would say, a mix pressure from catalyst sales or lack of catalyst cells in the second quarter. And it also gives us a little bit of pressure year-over-year. But as you remember, last year, second quarter was our strongest quarter on catalyst sales in the year. So on total year, I don't see any pressure to what we guided. In fact, I feel more confident that we'll deliver that 20 bps to 60 bps. We just have to get through the second quarter. In Aerospace, we talked about roughly being for the year at 26%, and that's kind of where it's going to be for the year. Vimal Kapur: I'll also add that the loss of revenue we're having in Middle East is also high-margin revenue. So that just has associated margin pressure because of services software, which has impacted the most due to disruptions there. So that becomes the additional driver because it's kind of high dis-synergies associated with that. Operator: Our next question comes from the line of Julian Mitchell with Barclays. Julian Mitchell: Just wanted to start off maybe with the PA&T organic sales ramp through the year. Help us understand kind of how we should be thinking about that? It sounds like you're still thinking sort of flattish for the year as a whole on organic sales, which is consistent with your prior guidance, but obviously a much tougher first half. So maybe sort of flesh out for us”